GT Biopharma, Inc. (GTBP)
0.44
+0.01
(+1.62%)
USD |
NASDAQ |
May 22, 16:00
0.4471
+0.01
(+1.61%)
After-Hours: 20:00
GT Biopharma Market Cap : 15.87M for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.613B |
| Alnylam Pharmaceuticals, Inc. | 39.71B |
| Amgen, Inc. | 183.12B |
| Savara, Inc. | 1.029B |
| Biogen, Inc. | 28.61B |
Market Cap Related Metrics
| PEG Ratio | -0.0002 |
| Price to Book Value | 2.094 |
| Price | 0.44 |
| Earnings Yield | -3.27K% |
| PEGY Ratio | -0.0002 |